In vivo toxicity of chitosan-based nanoparticles: a systematic review
Chitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety. Numerous toxicity studies have been previously conducted to assess the safety profile of chitosan-based nanoparticles....
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Artificial Cells, Nanomedicine, and Biotechnology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2025.2462328 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850108964326342656 |
|---|---|
| author | Shela Salsabila Miski Aghnia Khairinisa Nasrul Wathoni Irna Sufiawati Wan Ezumi Mohd Fuad Nur Kusaira Khairul Ikram Muchtaridi Muchtaridi |
| author_facet | Shela Salsabila Miski Aghnia Khairinisa Nasrul Wathoni Irna Sufiawati Wan Ezumi Mohd Fuad Nur Kusaira Khairul Ikram Muchtaridi Muchtaridi |
| author_sort | Shela Salsabila |
| collection | DOAJ |
| description | Chitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety. Numerous toxicity studies have been previously conducted to assess the safety profile of chitosan-based nanoparticles. These toxicity studies employed various methodologies, including test animals, interventions, and different routes of administration. This review aims to summarise research on the safety profile of chitosan-based nanoparticles in drug delivery, with a focus on general toxicity tests to determine LD50 and NOAEL values. It can serve as a repository and reference for chitosan-based nanoparticles, facilitating future research and further development of drugs delivery system using chitosan nanoparticles. Publications from 2014 to 2024 were obtained from PubMed, Scopus, Google Scholar, and ScienceDirect, in accordance with the inclusion and exclusion criteria.The ARRIVE 2.0 guidelines were employed to evaluate the quality and risk-of-bias in the in vivo toxicity studies. The results demonstrated favourable toxicity profiles, often exhibiting reduced toxicity compared to free drugs or substances. Acute toxicity studies consistently reported high LD50 values, frequently exceeding 5000 mg/kg body weight, while subacute studies typically revealed no significant adverse effects. Various routes of administration varied, including oral, intravenous, intraperitoneal, inhalation, and topical, each demonstrating promising safety profiles. |
| format | Article |
| id | doaj-art-ed2ec4dc3d1848198e99ed7ccd7bcce1 |
| institution | OA Journals |
| issn | 2169-1401 2169-141X |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Artificial Cells, Nanomedicine, and Biotechnology |
| spelling | doaj-art-ed2ec4dc3d1848198e99ed7ccd7bcce12025-08-20T02:38:13ZengTaylor & Francis GroupArtificial Cells, Nanomedicine, and Biotechnology2169-14012169-141X2025-12-0153111510.1080/21691401.2025.2462328In vivo toxicity of chitosan-based nanoparticles: a systematic reviewShela Salsabila0Miski Aghnia Khairinisa1Nasrul Wathoni2Irna Sufiawati3Wan Ezumi Mohd Fuad4Nur Kusaira Khairul Ikram5Muchtaridi Muchtaridi6Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Sumedang, IndonesiaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, IndonesiaDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, IndonesiaDepartment of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Sumedang, IndonesiaProgramme of Biomedicine, School of Health Sciences, USM Health Campus, Kubang Kerian, Kelantan, MalaysiaInstitute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur, MalaysiaDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Sumedang, IndonesiaChitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety. Numerous toxicity studies have been previously conducted to assess the safety profile of chitosan-based nanoparticles. These toxicity studies employed various methodologies, including test animals, interventions, and different routes of administration. This review aims to summarise research on the safety profile of chitosan-based nanoparticles in drug delivery, with a focus on general toxicity tests to determine LD50 and NOAEL values. It can serve as a repository and reference for chitosan-based nanoparticles, facilitating future research and further development of drugs delivery system using chitosan nanoparticles. Publications from 2014 to 2024 were obtained from PubMed, Scopus, Google Scholar, and ScienceDirect, in accordance with the inclusion and exclusion criteria.The ARRIVE 2.0 guidelines were employed to evaluate the quality and risk-of-bias in the in vivo toxicity studies. The results demonstrated favourable toxicity profiles, often exhibiting reduced toxicity compared to free drugs or substances. Acute toxicity studies consistently reported high LD50 values, frequently exceeding 5000 mg/kg body weight, while subacute studies typically revealed no significant adverse effects. Various routes of administration varied, including oral, intravenous, intraperitoneal, inhalation, and topical, each demonstrating promising safety profiles.https://www.tandfonline.com/doi/10.1080/21691401.2025.2462328Drug-coatedchitosan nanoparticlestoxicityLD50NOAEL |
| spellingShingle | Shela Salsabila Miski Aghnia Khairinisa Nasrul Wathoni Irna Sufiawati Wan Ezumi Mohd Fuad Nur Kusaira Khairul Ikram Muchtaridi Muchtaridi In vivo toxicity of chitosan-based nanoparticles: a systematic review Artificial Cells, Nanomedicine, and Biotechnology Drug-coated chitosan nanoparticles toxicity LD50 NOAEL |
| title | In vivo toxicity of chitosan-based nanoparticles: a systematic review |
| title_full | In vivo toxicity of chitosan-based nanoparticles: a systematic review |
| title_fullStr | In vivo toxicity of chitosan-based nanoparticles: a systematic review |
| title_full_unstemmed | In vivo toxicity of chitosan-based nanoparticles: a systematic review |
| title_short | In vivo toxicity of chitosan-based nanoparticles: a systematic review |
| title_sort | in vivo toxicity of chitosan based nanoparticles a systematic review |
| topic | Drug-coated chitosan nanoparticles toxicity LD50 NOAEL |
| url | https://www.tandfonline.com/doi/10.1080/21691401.2025.2462328 |
| work_keys_str_mv | AT shelasalsabila invivotoxicityofchitosanbasednanoparticlesasystematicreview AT miskiaghniakhairinisa invivotoxicityofchitosanbasednanoparticlesasystematicreview AT nasrulwathoni invivotoxicityofchitosanbasednanoparticlesasystematicreview AT irnasufiawati invivotoxicityofchitosanbasednanoparticlesasystematicreview AT wanezumimohdfuad invivotoxicityofchitosanbasednanoparticlesasystematicreview AT nurkusairakhairulikram invivotoxicityofchitosanbasednanoparticlesasystematicreview AT muchtaridimuchtaridi invivotoxicityofchitosanbasednanoparticlesasystematicreview |